m2M consortium dissemination highlights & upcoming agenda

Open collaboration accelerates the path from laboratory research to validated therapies. Through m2M, our European consortium is turning this principle into practice, developing next-generation bioprinting solutions for joint regeneration.

Knowledge sharing, clinical alignment, and stakeholder engagement across Europe drive every phase of our work. Below is a review of our recent scientific presentations and a forward look at where you can connect with our researchers next.

Where We have been

Our consortium members have been actively presenting m2M’s technological and biological advancements across premier orthopaedic and biomaterials symposia.

Featured Symposium at the European Orthopaedic Research Society (EORS) – Madrid, Spain

At the 2026 EORS Annual Meeting in Madrid, m2M organized a major dedicated session on Bioengineering / Biomechanics – Emerging Biofabrication and Bioprinting Strategies for the Engineering of Functional Musculoskeletal Tissues.

Chaired by Daniel Kelly and with Rita Sobreiro-Almeida and Jos Malda, the symposium showcased pivotal contributions from the m2M partnership.

International Scientific Visits & Specialist Workshops (Autumn 2026)

  • The Feinstein Institutes for Medical Research / Atrium Health (New York, USA)
  • Havemeyer Workshop on Equine Regenerative Medicine (1–4 November 2026)

Where to Find Us Next

The consortium is preparing for a dense schedule of lectures, technical schools, and governance milestones across 2027. Mark your calendar to meet our teams at these key dates:

TERMIS Winter School on Regenerative Medicine (8–10 January 2027 | Radstadt, Austria)

ISBF Winter School on Biofabrication (11–13 January 2027 | Radstadt, Austria)

Gordon Research Conference: Cartilage Biology and Pathology (7–10 March 2027 | Italy)

ICRS World Congress (1–3 May 2027 | Rotterdam, The Netherlands)

Annual Biofabrication Summer School (12–16 July 2027 | Utrecht, The Netherlands)

Join Our Journey

We invite researchers, clinicians, medtech entrepreneurs, and patient advocates to connect with our speakers at these events or explore joint dissemination initiatives.

Follow the m2M Project on LinkedIn to receive the latest open-access results and cluster activities directly.